EnWave Announces Start-up of Pilot-Scale quantaREV(TM) Technology

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 20, 2011) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") announced the successful startup of their pilot-scale quantaREV™ dehydration technology at the Company's pilot plant facility in Delta, British Columbia. EnWave has now initiated specific product testing on the machine and plans to begin customer testing in late September. Moreover, the Company plans to build five additional lab-scale REV units over the course of this year to increase availability for expected on-going paid testing and collaborations.

EnWave had previously conducted successful testing on a lab-scale quantaREV™ machine at the company's facilities earlier this year. quantaREV™ is designed to meet the requirements of food and chemical production companies for high-volume continuous, low-temperature dehydration of solids, liquids, granular or encapsulated products. quantaREV™ introduces a continuous belt design within a controlled vacuum-microwave environment, allowing the potential for dehydration of up to several tonnes of material per hour, a significant innovation in EnWave's REV dehydration technology.

"We are tremendously excited to begin quantaREV™ testing with our current and potential collaborators," stated Dr. Tim Durance, EnWave's Chairman and Co-CEO. "We expect the efficiency and scalability of quantaREV™ to make REV an attractive technology for large scale processing of high quality food ingredients and snacks, as well as chemical and industrial applications."

EnWave's new quantaREV™ dehydration technology uses a proprietary continuous belt design in a uniquely controlled vacuum-microwave environment in order to accommodate a wide range of input materials. quantaREV™ will complement EnWave's current suite of dehydration technologies which include nutraREV™, a commercial technology used for drying discrete food pieces tumbling in a vacuum-microwave environment, and powderREV™, an accelerated freeze drying process currently being tested as a means for bulk drying of biomaterials such as probiotics and enzymes. The Company also has two other prototype dehydration technologies, bioREV™ and freezeREV™, both of which are designed to dry biomaterials in vials such as vaccines and other biopharmaceuticals, scientific reagents, and medical diagnostic materials.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. In collaboration with an expanding list of multinational partners, including Nestlé, Kellogg's, Danisco, Grupo Bimbo, Grimmway Farms and Bonduelle. EnWave is introducing REV as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has six REV platforms: commercial-scale nutraREV™ and MIVAP™ are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.